Artiklar

{{ window.visitor.ipAccess.corporateClient.name }}
Welcome to our Corporate client solution

Your IP is registered with the company mentioned above and provides access to Life Science Sweden.
Click here to go to sign-up

Sortering: Sida Sida av 1

Biosimilars bring price pressure, but are they sufficiently used?
September 28 2022
biosimilars? The answer partly depends on whom you ask.
Investments worth 40 billion in the Öresund region – “A huge investment wave”
Maj 16 2022
A new report reveals that medical companies in the Oresund region are investing like never before.

Resultat per sida: Sida Sida av 1

BREAKING

{{ article.headline }}

0.11|instance-web04